Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2020-07-28 Regulatory Filings
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2020-07-28 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS OF THE SECOND SESSION OF THE BOARD
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles and functions, including details about board committees and their composition. It does not contain financial data, earnings, or regulatory filings but focuses on governance structure and board composition. This matches the description of Board/Management Information (MANG), which covers announcements of changes or details about the company's board of directors or senior management. The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS. Therefore, the correct classification is MANG.
2020-07-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2020-07-23 English
Articles of Association
Governance Information Classification · 95% confidence The document is titled 'Articles of Association' for Pharmaron Beijing Co., Ltd., dated June 2020 revision. It contains detailed chapters on company governance, share issuance, board of directors, shareholders' meetings, financial and accounting systems, and other corporate governance matters. The content is a legal and governance framework document regulating the organization and activities of the company, its shareholders, directors, and management. It is not a financial report, earnings release, or announcement of voting results. It is a governance document outlining internal rules and structure. Therefore, it fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full Articles of Association, not just an announcement or summary.
2020-07-23 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles, including executive, non-executive, and independent non-executive directors. It also mentions the upcoming meeting to elect members and chairmen of board committees. There is no financial data, no report or announcement of voting results, no legal or regulatory filings, and no mention of dividends or capital changes. The content is clearly about the composition and structure of the board and management. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short but contains substantive information about board members, not just an announcement or notice.
2020-07-23 English
(I) POLL RESULTS OF THE SECOND EXTRAORDINARY GENERAL MEETING OF 2020 HELD ON JULY 23, 2020&#x3b; (II) RETIREMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS&#x3b; (III) APPOINTMENT OF DIRECTORS OF THE SECO
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results of an Extraordinary General Meeting (EGM) held on July 23, 2020. It details voting outcomes on resolutions including retirement and appointment of directors and supervisors, and amendments to the Articles of Association. The content focuses on shareholder meeting results and board changes rather than financial performance or detailed management discussion. It is not a full annual or interim report, nor a call transcript or earnings release. The document is lengthy (over 12,000 characters) and contains detailed voting results and board appointments, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-07-23 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.